Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Waldorf Astoria New York Hosts Artist-in-Residence Evi Photopoulos Now Through November 7
-
Perspective’s [212Pb]Bamzireotide Navoxetan (VMT-α-NET) Demonstrates Encouraging Safety, Durable Disease Control, and Robust Tumor Response Across Multiple Dose Cohorts in Phase 1/2a Trial in Advan
-
FHLBank Atlanta Invests $20 Million in State Housing Bonds to Expand Access to Homeownership
-
Northern Virginia Housing Remains Tighter Than Nationally Despite Inventory Surge
-
Study Finds Lower Rates of Overweight Among Vegan-Fed Cats
-
Amid Rising Costs and Surgical Disruptions in ASCs, NorthStar Anesthesia Strengthens Focus on ASC Partnerships
-
Middlefield ActivEnergy Dividend Class ETF Series Distributions
-
In HelloNation, Insurance Agent John Scalise Explains Liability Gaps in Alpharetta and Fulton County Homes
-
RBC iShares / BlackRock (XBAI) Opens the Market
-
This Is Her Podcast Streams on Channel 1029 Across Three TV Platforms
-
Mitsubishi Motors Begins Sales of the All-New Pajero Cross-Country SUV in Thailand
-
Middlefield Short Duration Bond Plus ETF Distributions
-
/C O R R E C T I O N - Tierra Del Sol and JOIA Aruba by Iberostar/
-
Middlefield U.S. Equity Dividend ETF Distributions
-
FT Portfolios Canada Co. Announces Cash Distributions for Its Exchange Traded Funds
-
2026 Sands Shopping Carnival Attracts Nearly 160,000 Visitors Over Four Days To Support Macao Businesses
-
Middlefield Real Estate Dividend ETF Distributions
-
THE POWER OF WILL: A SERIES OF CONVERSATIONS ABOUT DETERMINATION AND INDIVIDUALITY
-
AMAZON TOM TEAM DRIVERS AT OIL9 FACILITY JOIN TEAMSTERS
-
Your Holiday Business Is Live. How Do You Get Customers
-
Why Are Commercial Construction Bids in Phoenix So Different for the Same Project?
-
Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MS
-
eClinicalWorks and healow Announce Record Revenues Exceeding $1.3 Billion for 2026, Driven by Accelerating AI Adoption
-
Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026
-
GOA Therapeutics Presents New Data at ANESTHESIOLOGY® 2026 for GOA26, a First-in-Class Candidate for Acute Alcohol Intoxication and Poisoning
-
NORVAULT AG extends Bacon Series 001 offer and tender timetable
-
LA Kings and LA Galaxy Invest in Long-Term Access to Community Recreation in Torrance
-
SEC Announces Fiscal Year 2027 Examination Priorities
-
CTS Corporation Announces Completion of the Acquisition of Millar Holdings
-
Astra Security Releases Free Tools to Help Organizations Find and Fix PHP2Shell Vulnerabilities
-
Final Days for Minnesota Technology Executives to Register for HMG Strategy’s Minneapolis Summit
-
Middlefield Global Infrastructure Dividend ETF Distributions
-
Nitches, Inc. (OTC: NICH) Takes NutraVeri to Both Sides of the $200 Billion Supplement Market: Free Checks for Consumers, Readiness Intelligence for Brands
-
Davidson Kempner Capital Management LP : Form 8.3 - easyJet plc
-
Middlefield Healthcare Dividend ETF Distributions
-
Lassa introduces new winter tyre Wintus 3 for light commercial vehicles
-
Important Notice to Long-Term Shareholders of Coastal Financial Corporation (NASDAQ: CCB); D-Wave Quantum Inc. (NASDAQ: QBTS); Erasca, Inc. (NASDAQ: ERAS) and Planet Fitness, Inc. (NYSE: PLNT): Grabar
-
Invisors deepens investment in Professional & Business Services with the PayBill Suite for Workday
-
Middlefield Global Dividend Growers ETF Distributions
-
Travelzoo Q3 2026 Earnings Conference Call on October 27 at 11:00 AM ET
-
Insurance Expert Peggy Schneider Discusses Replacement Cost vs. Actual Cash Value in HelloNation
-
Insurity Showcases the Next Generation of Intelligent Insurance Software at Largest Excellence in AI & Insurance Conference Yet
-
Summers Plumbing Heating & Cooling Joins K99.1FM Cares for Kids Radiothon as Phone Bank Sponsor
-
Ziihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026
-
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
-
Deutsche Bank Poised to Set High Standard for Digital Currency Custody
-
Mesh Leans on Visa to Enable Seamless Crypto Use
-
How to Secure Community Buy-In for Renewable Energy Projects
-
Electricity Use by Semiconductor Industry in Taiwan Reaches Record Level
-
Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026
